Regulatory News

May 8, 2018 / 9:54 PM / 17 days ago

BRIEF-EyePoint Pharmaceuticals Reports Q3 Loss Per Share $0.15

Reuters Staff

1 Min Read

May 8 (Reuters) - EyePoint Pharmaceuticals Inc:

* EYEPOINT PHARMACEUTICALS REPORTS FISCAL THIRD QUARTER 2018 RESULTS

* Q3 REVENUE VIEW $723,000 — THOMSON REUTERS I/B/E/S

* Q3 EARNINGS PER SHARE VIEW $-0.13 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below